articl
introduc
seri
invit
paper
antivir
research
mark
anniversari
outbreak
sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
emerg
southern
china
late
time
coronavirus
recogn
agent
caus
sever
diseas
human
henc
emerg
sarscov
came
complet
surpris
research
past
ten
year
reveal
exist
divers
pool
coronavirus
circul
among
variou
bat
speci
anim
suggest
introduct
highli
pathogen
coronavirus
human
popul
mere
probabl
inevit
recent
emerg
anoth
coronaviru
caus
sever
diseas
middl
east
respiratori
syndrom
mer
human
made
clear
coronavirus
pose
major
threat
human
health
research
urgent
need
elucid
replic
mechan
identifi
potenti
drug
target
develop
effect
countermeasur
seri
expert
mani
differ
aspect
coronaviru
replic
diseas
provid
authorit
uptod
review
follow
topic
clinic
manag
infect
control
sar
reservoir
host
coronavirus
receptor
recognit
crossspeci
transmiss
sarscov
sarscov
evas
innat
immun
respons
structur
function
individu
coronavir
protein
anticoronaviru
drug
discoveri
develop
public
health
legaci
sar
outbreak
articl
identifi
last
line
abstract
belong
seri
sar
mer
year
research
highli
pathogen
human
coronavirus
rememb
past
condemn
repeat
georg
santayana
ten
year
ago
novel
coronaviru
caus
pneumonia
human
emerg
guangdong
china
first
known
patient
old
man
citi
foshan
develop
fever
respiratori
symptom
novemb
transmit
infect
wife
three
famili
member
second
index
case
restaur
chef
shenzhen
becam
ill
decemb
return
home
heyuan
transmit
infect
health
care
worker
hcw
local
hospit
includ
physician
accompani
ambul
guangzhou
provinci
hospit
scenario
emerg
cluster
case
sever
respiratori
diseas
among
famili
member
hospit
worker
cluster
appar
go
extinct
round
secondari
tertiari
transmiss
play
repeatedli
subsequ
week
number
municip
guangdong
provinc
index
case
mani
earli
case
cluster
food
handler
chef
work
restaur
varieti
exot
game
anim
slaughter
premis
xu
et
al
subsequ
week
outbreak
becam
selfsustain
larg
cluster
transmiss
hospit
spill
back
commun
tabl
first
superspread
event
becam
hallmark
epidemiolog
diseas
occur
hospit
old
man
guangzhou
januari
transmit
infect
rel
hospit
staff
februari
one
doctor
infect
part
extend
hospit
outbreak
travel
hong
kong
stay
one
night
hotel
hospitalis
next
day
stay
transmit
infect
hotel
guest
one
visitor
travel
destin
seed
outbreak
diseas
vietnam
singapor
toronto
hong
kong
march
follow
outbreak
mainland
china
hong
kong
vietnam
world
health
organ
issu
global
alert
unusu
pneumonia
appear
caus
outbreak
diseas
hospit
led
recognit
report
addit
case
cluster
toronto
singapor
prompt
issu
emerg
travel
advisori
march
provid
earli
case
definit
name
di
tabl
sar
aftermath
chronolog
event
past
ten
year
partli
base
western
pacif
region
region
chronolog
event
sar
outbreak
provid
tabl
stage
number
possibl
aetiolog
agent
propos
includ
chlamydia
paramyxovirus
human
metapneumoviru
coronaviru
among
other
coordin
share
inform
among
laboratori
result
consensu
etiolog
agent
novel
coronaviru
name
sar
coronaviru
sarscov
ksiazek
et
al
drosten
et
al
kuiken
et
al
whomedi
informationshar
allow
laboratori
epidemiologist
clinician
achiev
rapid
consensu
clinic
virolog
patient
manag
viru
transmiss
world
health
organ
multicentr
collabor
network
sever
acut
respiratori
syndrom
diagnosi
sar
spread
rapidli
along
rout
airtravel
affect
countri
territori
across
five
contin
sicken
peopl
lead
death
almost
fortun
unusu
featur
permit
success
basic
public
health
measur
control
persontoperson
transmiss
viral
load
upper
respiratori
tract
secret
low
first
day
ill
increas
progress
peak
earli
second
week
see
cheng
et
al
seri
result
transmiss
less
common
first
day
ill
provid
opportun
case
detect
isol
interrupt
transmiss
patient
infecti
hospitalis
contribut
transmiss
hospit
especi
develop
set
invas
potenti
aerosolgener
intervent
bronchoscopi
like
carri
sarscov
also
unusu
stabl
environ
coronavirus
respiratori
virus
make
infect
control
hospit
challeng
see
cheng
et
al
seri
specul
enhanc
stabil
sarscov
lower
temperatur
lower
humid
especi
aircondit
environ
may
help
explain
explos
outbreak
occur
region
compar
other
chan
et
al
howev
awar
grew
patient
began
identifi
hospit
earlier
ill
leung
et
al
effect
infect
control
modal
better
implement
becam
possibl
interrupt
transmiss
commun
hospit
thu
juli
possibl
announc
known
chain
humantohuman
transmiss
sar
viru
appear
broken
outcom
could
hardli
imagin
dark
day
marchapril
exampl
unpreced
cluster
around
case
emerg
day
amoy
garden
hous
estat
hong
kong
outbreak
end
zoonot
sourc
viru
still
remain
identifi
epidemiolog
investig
found
index
patient
initi
case
cluster
novemberdecemb
food
handler
restaur
worker
especi
expos
exot
wildgam
anim
regard
winter
delicaci
southern
china
increas
affluenc
past
decad
led
trade
becom
highli
organis
commercialis
hundr
divers
exot
wildlif
hous
larg
central
market
investig
wet
market
led
detect
viru
close
relat
sarscov
rang
small
mammalian
speci
himalayan
palm
civet
paguma
larvata
raccoon
dog
nyctereut
procyonoid
other
peopl
work
market
high
preval
antibodi
sarscov
even
though
gave
histori
sar
peopl
work
area
market
veget
stall
peopl
commun
identifi
wildgam
anim
market
interfac
facilit
mainten
amplif
sarscov
precursor
virus
allow
repeat
exposur
human
popul
lead
interspeci
transmiss
event
late
earli
four
patient
sarslik
ill
diagnos
phylogenet
reemerg
virus
close
relat
virus
found
time
gameanim
market
caus
sar
epidem
year
confirm
content
wet
market
sourc
initi
human
infect
led
closur
like
preempt
reemerg
sar
work
establish
wildcaught
palm
civet
show
evid
sarscov
infect
suggest
intermedi
amplifi
host
rather
true
reservoir
novel
coronavirus
includ
close
relat
sarscov
identifi
bat
includ
insectivor
rhinolophid
bat
li
et
al
lau
et
al
see
drexler
et
al
seri
subsequ
work
identifi
virusreceptor
interact
receptor
restrict
permit
restrict
interspeci
transmiss
event
sarscovlik
virus
li
et
al
see
review
f
li
seri
earli
phase
epidem
physician
manag
sever
ill
patient
includ
colleagu
without
reliabl
knowledg
viru
suscept
antivir
drug
treatment
regimen
appli
describ
detail
cheng
et
al
seri
initi
patient
given
ribavirin
broadli
activ
antivir
compound
effect
rna
virus
hepat
c
viru
lassa
viru
retrospect
show
littl
benefit
sar
patient
vitro
activ
ribavirin
sarscov
replic
cell
cultur
gave
contradictori
result
depend
cell
type
use
cinatl
et
al
morgenstern
et
al
mani
sar
patient
treat
combin
ribavirin
corticosteroid
mix
result
see
cheng
et
al
seri
interferona
administ
patient
mainland
china
toronto
canada
report
china
benefici
effect
could
clearli
ascrib
interferona
alway
use
combin
immunoglobulin
thymosin
zhao
et
al
preliminari
uncontrol
studi
toronto
suggest
treatment
combin
interferona
corticosteroid
superior
corticosteroid
alon
loutfi
et
al
sarscovinfect
cell
cultur
interferonb
much
superior
effect
interferona
cinatl
et
al
polyethyleneglycolmodifi
interferona
demonstr
protect
macaqu
sarscov
prophylact
reduc
viral
replic
tissu
patholog
administ
therapeut
haagman
et
al
interestingli
hivproteas
inhibitor
lopinavir
often
combin
ritonavir
appear
show
benefit
sar
patient
chu
et
al
see
review
cheng
et
al
seri
antivir
effect
compound
also
observ
cell
cultur
coronaviru
genom
code
aspart
proteas
relat
hiv
proteas
wu
et
al
test
potenc
lopinavir
isol
sarscov
main
proteas
also
call
proteas
pro
cystein
proteas
found
ic
around
lm
low
potenc
probabl
suffici
explain
benefici
effect
lopinavirritonavir
clinic
treatment
sar
patient
ritonavir
known
boost
immun
system
explain
observ
activ
cell
cultur
altern
explan
could
antiapoptot
activ
hiv
proteas
inhibitor
maturres
et
al
inform
propos
bind
mode
lopinavir
sarscov
main
proteas
attempt
improv
inhibitori
potenc
present
review
molecular
target
seri
zhang
et
al
mainland
china
tradit
chines
medicin
tcm
employ
addit
one
therapi
describ
difficult
assess
effect
systemat
studi
carri
see
cheng
et
al
seri
tcm
antisarscov
activ
demonstr
cell
cultur
rel
high
concentr
glycyrrhizin
compound
found
liquoric
cinatl
et
al
within
three
week
discoveri
sarscov
complet
nucleotid
sequenc
determin
marra
et
al
rota
et
al
make
ration
approach
antivir
drug
discoveri
possibl
exampl
luo
et
al
notic
sequenc
similar
sarscov
nucleocapsid
n
protein
capsid
protein
ca
hiv
latter
bind
cyclophilin
cypa
peptidyl
prolyl
cistran
isomeras
host
cell
incorpor
hiv
particl
gambl
et
al
accordingli
luo
et
al
reason
n
protein
sarscov
may
also
bind
cypa
could
inde
determin
k
valu
nm
interact
block
cyclosporin
inhibitor
cypa
howev
use
immunosuppress
drug
virtual
screen
techniqu
employ
model
sarscov
ncypa
complex
target
luo
et
al
abl
identifi
inhibitor
interact
show
degre
cell
toxic
chen
et
al
confirm
interact
cypa
n
protein
even
provid
evid
incorpor
cypa
virion
similar
shown
previous
howev
sar
epidem
idea
block
sarscov
replic
inhibit
cypa
follow
pfefferl
et
al
detect
specif
interact
cypa
sarscov
nonstructur
protein
similarli
yeasttwohybrid
proteinprotein
interact
techniqu
see
articl
von
brunn
colleagu
seri
consequ
test
csa
antivir
effect
larg
rang
coronavirus
found
pancoronaviru
inhibitor
pfefferl
et
al
see
also
de
wild
et
al
howev
csa
also
display
antivir
activ
ccoronaviru
infecti
bronchiti
viru
ibv
lack
possibl
mechan
origin
propos
luo
et
al
may
contribut
csa
anticoronavir
activ
malauer
et
al
interestingli
anecdot
report
cyclosporin
occasion
use
treat
sar
patient
eg
et
al
effort
design
antisar
drug
initi
earli
outbreak
hamper
lack
structur
data
molecular
target
end
march
sarscov
discov
etiolog
agent
caus
diseas
one
crystal
structur
coronaviru
protein
avail
main
proteas
pro
pro
porcin
coronaviru
transmiss
gastroenter
viru
tgev
anand
et
al
howev
midmay
peak
sar
outbreak
beij
group
publish
first
structur
synthet
inhibitor
peptidyl
methyl
keton
bound
tgev
pro
well
structur
second
coronaviru
pro
human
coronaviru
homolog
model
sarscov
enzym
base
structur
furthermor
author
suggest
rupintrivir
michaelacceptortyp
inhibitor
proteas
human
rhinoviru
good
start
point
antisar
drug
design
littl
later
compound
shown
littl
activ
viru
shie
et
al
deriv
rupintrivir
turn
quit
activ
virusinfect
cell
cultur
shie
et
al
yang
et
al
studi
facilit
determin
crystal
structur
sarscov
main
proteas
june
sinc
mani
inhibitor
design
synthes
target
coronaviru
pro
undergon
systemat
toxic
preclin
studi
compound
yet
avail
clinic
trial
case
recurr
sar
treatment
patient
infect
new
human
coronaviru
merscov
see
numer
studi
aim
design
inhibitor
coronaviru
main
proteas
summar
zhang
et
al
seri
coronavirus
envelop
virus
singlestrand
rna
genom
posit
polar
largest
known
rna
genom
size
kb
kb
case
sarscov
open
read
frame
orf
sarscov
genom
code
least
protein
fig
structur
protein
encod
termin
third
genom
spike
glycoprotein
protrud
surfac
viral
particl
henc
name
coronaviru
respons
receptor
bind
membran
fusion
late
angiotensinconvert
enzym
identifi
receptor
sarscov
surfac
human
cell
wang
et
al
structur
complex
receptorbind
domain
sarscov
spike
protein
determin
li
et
al
review
subsequ
work
seri
proteolyt
process
protein
prerequisit
membran
fusion
review
simmon
colleagu
inhibitor
hostcel
proteas
involv
also
shown
prevent
cell
entri
sarscov
see
eg
adedeji
et
al
peptid
correspond
heptad
repeat
trimer
protein
demonstr
inhibit
fusion
viral
envelop
hostcel
membran
eg
sainz
et
al
liu
et
al
anoth
import
structur
protein
coronavirus
nucleocapsid
n
protein
encapsul
genom
rna
role
replic
transcript
see
eg
tylor
et
al
grossoehm
et
al
current
knowledg
protein
review
huang
colleagu
seri
matrix
protein
envelop
e
glycoprotein
complet
structur
protein
although
case
sarscov
accessori
protein
see
also
believ
incorpor
viral
particl
compris
twothird
sarscov
genom
code
two
huge
polyprotein
kd
kd
ribosom
slippag
frameshift
site
near
terminu
lead
translat
entir
nami
et
al
polyprotein
process
two
viral
cystein
proteas
papainlik
proteas
pl
pro
domain
main
proteas
pro
pro
total
nonstructur
protein
nsp
compon
viral
replicationtranscript
complex
rtc
may
also
adopt
addit
function
review
see
sawicki
et
al
sawicki
et
al
pasternak
et
al
master
perlman
netland
rtc
consist
major
coronavir
nsp
yet
unidentifi
host
protein
assembl
virusinduc
doublemembran
vesicl
dmv
unusu
membran
structur
deriv
er
membran
knoop
et
al
recent
year
signific
progress
made
unravel
structur
dmv
review
snijder
colleagu
seri
assembl
rtc
nest
set
sub
genom
mrna
synthes
subsequ
translat
structur
accessori
protein
sawicki
et
al
pasternak
et
al
final
structur
protein
assembl
progeni
virion
along
newli
synthes
genom
rna
bud
membran
intermedi
ertogolgi
compart
krijnselock
et
al
matur
virion
egress
host
cell
via
exocytosi
obvious
essenti
role
coronavir
proteas
target
intens
structur
function
mechanist
inhibitordiscoveri
studi
dealt
separ
review
seri
mesecar
baker
colleagu
pl
pro
zhang
et
al
pro
signific
progress
also
made
past
year
elucid
structur
nsp
hope
learn
someth
function
tabl
list
structur
known
date
effort
made
possibl
sever
structur
proteom
project
bartlam
et
al
canard
et
al
hilgenfeld
et
al
overal
approach
quit
success
although
protein
mostli
encod
know
structur
function
still
quit
clear
mani
case
domain
pl
pro
also
partli
tabl
contrast
sever
protein
mostli
encod
know
function
littl
structur
inform
avail
pain
lack
structur
inform
concern
rnadepend
rnapolymeras
rdrp
helicas
obviou
drug
target
progress
character
domain
pl
pro
summar
lei
et
al
xiao
et
al
canard
colleagu
articl
seri
final
sarscov
genom
encod
sever
accessori
protein
undergo
rapid
evolut
exampl
earli
sar
outbreak
code
one
protein
evolut
viru
earli
lost
nucleotid
subsequ
code
two
separ
accessori
protein
thought
event
respons
increas
effici
humantohuman
transmiss
surfac
time
trigger
epidem
chines
sar
molecular
epidemiolog
consortium
oostra
et
al
structur
inform
sarscov
accessori
protein
still
scarc
see
tabl
partli
due
fact
mani
gene
product
membran
protein
present
seri
articl
accessori
protein
sarscov
review
dx
liu
colleagu
evolutionari
aspect
sarscov
subject
articl
gorbalenya
colleagu
sar
epidem
vividli
demonstr
live
global
villag
infecti
diseas
emerg
anywher
world
potenti
spread
global
short
period
time
one
legaci
outbreak
formul
intern
health
regul
ihr
http
wwwwhoint
ihren
accept
world
health
assembl
ihr
requir
countri
report
unusu
unexplain
outbreak
infecti
diseas
develop
public
health
capac
detect
respond
diseas
occur
seri
see
review
p
gulli
sar
contemporari
zoonot
threat
avian
influenza
highlight
need
collabor
among
respons
human
anim
health
environ
led
formal
concept
one
health
foster
collabor
effect
multipl
disciplin
attain
optim
health
peopl
anim
environ
relev
intern
organ
food
agricultur
organ
fao
world
organis
anim
health
oie
formal
agreement
framework
within
coordin
activ
assess
risk
animalhuman
ecosystem
interfac
faooiewho
collabor
see
http
wwwwhointinfluenzaresourcesdocumentstripartiteconcept
access
august
sar
also
contribut
enhanc
emphasi
place
better
understand
viral
divers
wildlif
need
understand
ecolog
biolog
base
interspeci
transmiss
pathogen
ten
year
sar
outbreak
worth
recount
event
detail
summaris
subsequ
understand
sarscov
continu
confront
novel
emerg
diseas
threat
due
increas
research
effort
two
addit
human
coronavirus
hcov
hcov
discov
van
der
hoek
et
al
woo
et
al
saw
anoth
novel
coronaviru
emerg
middl
east
zaki
et
al
novel
middl
east
respiratori
syndrom
mer
coronaviru
betacoronaviru
like
sarscov
belong
lineag
c
rather
b
see
drexler
et
al
seri
caus
sever
pneumonia
well
renal
failur
high
fatal
rate
index
case
origin
jordan
qatar
saudi
arabia
unit
arab
emir
travelassoci
case
diagnos
franc
germani
itali
tunisia
uk
septemb
case
confirm
death
http
wwwwhointcsr
mer
patient
tend
elderli
underli
ill
secondari
transmiss
report
hospit
one
event
franc
diseas
appear
highli
transmiss
healthi
hcw
instead
target
patient
immunocompromis
maill
et
al
largest
cluster
case
report
health
facil
alahsa
eastern
provinc
saudi
arabia
transmiss
patient
famili
member
well
hcw
occur
assiri
et
al
contrast
sar
rel
hcw
affect
far
although
virus
close
relat
merscov
detect
pipistrellu
bat
found
europ
africa
epidemiolog
plausibl
zoonot
sourc
phylogenet
proxim
viru
remain
identifi
see
drexler
et
al
seri
annan
et
al
recent
high
neutralizingantibodi
titer
merscov
detect
dromedari
camel
oman
egypt
suggest
may
intermedi
transmitt
viru
perera
et
al
event
uncannili
reminisc
emerg
sar
late
seroepidemiolog
studi
need
defin
full
extent
secondari
transmiss
merscov
whether
infect
widespread
commun
receptor
merscov
identifi
dipeptidyl
peptidas
iv
express
human
respiratori
tract
conserv
across
mani
speci
includ
bat
biolog
understand
glean
viralhost
receptor
interact
restrict
interspeci
transmiss
sarscov
see
review
li
seri
relev
merscov
two
crystal
structur
complex
receptorbind
domain
rbd
merscov
spike
protein
publish
recent
lu
et
al
wang
et
al
structur
rbd
alon
chen
et
al
see
review
f
li
seri
crystal
structur
merscov
main
proteas
also
commun
ren
et
al
articl
macrodomain
viru
lei
et
al
prepar
structur
includ
review
seri
describ
individu
protein
sarscov
merscov
merscov
appear
replic
effici
human
respiratori
tissu
chan
et
al
target
alveolar
epitheli
cell
endothelium
blood
vessel
lung
indic
potenti
dissemin
beyond
respiratori
tract
seen
sarscov
see
cheng
et
al
seri
sarscov
novel
coronaviru
appear
avoid
elicit
host
interferon
respons
remain
sensit
action
interferon
see
review
frieman
baric
colleagu
seri
chan
et
al
falzarano
et
al
de
wild
et
al
therapeut
option
tri
sar
includ
interferon
therapi
summar
cheng
et
al
seri
may
pertin
mer
lesson
yet
learn
current
statu
antivir
therapi
vaccin
develop
sar
mer
huge
progress
made
past
ten
year
elucid
function
structur
protein
sarscov
research
vaccin
develop
also
progress
number
strategi
develop
evalu
experiment
anim
model
howev
also
note
becam
difficult
obtain
fund
research
sarscov
mani
countri
especi
effort
discov
new
antivir
therapi
similarli
incent
develop
sarscov
vaccin
absenc
overt
threat
human
health
fund
agenc
peer
review
probabl
shortsight
respect
mani
virologist
also
fail
take
serious
threat
reemerg
sar
sarslik
viru
even
though
mani
inhibitor
sarscov
main
proteas
design
basi
crystal
structur
see
review
zhang
et
al
seri
test
sarscovinfect
cell
cultur
let
alon
anim
model
prime
drug
target
among
viral
nonstructur
protein
rdrp
helicas
situat
even
discourag
difficult
obtain
enzym
activ
form
numer
attempt
crystal
fail
thu
frustrat
conclus
ten
year
excel
basic
research
sarscov
still
left
therapi
show
uncertain
effect
treatment
patient
ie
interferona
lopinavirritonavir
seem
offer
specif
antivir
treatment
mer
patient
recent
shown
merscovinfect
rhesu
macaqu
cours
diseas
much
milder
upon
treatment
combin
ribavirin
falzarano
et
al
larg
neg
experi
treat
sar
patient
corticosteroid
longer
treatment
option
may
hope
nonimmunosuppress
deriv
cyclosporin
use
therapi
compound
remain
test
virusinfect
cell
cultur
also
peptid
ketoamid
design
basi
crystal
structur
pro
bat
coronaviru
highli
similar
correspond
enzym
merscov
appear
promis
good
antivir
activ
merscov
lin
et
al
prepar
bunsatur
ester
et
al
prepar
howev
compound
safeti
studi
anim
take
long
time
use
clinic
current
merscov
outbreak
danger
fund
enthusiasm
develop
compound
wane
drugless
situat
next
zoonot
transmiss
coronaviru
human
popul
occur
conjunct
produc
novel
antivir
need
develop
consolid
global
network
rapidli
respond
emerg
infecti
diseas
crise
mer
novel
therapeut
option
may
scientif
evalu
control
clinic
trial
exampl
network
emerg
includ
isar
intern
sever
acut
respiratori
emerg
infect
consortium
global
initi
aim
ensur
clinic
research
open
access
protocol
datashar
process
need
facilit
rapid
respons
emerg
diseas
may
turn
epidem
pandem
http
isarictghnorg
regard
vaccin
develop
longliv
neutral
antibodi
respons
recov
sar
provid
hope
activ
passiv
immun
strategi
feasibl
least
principl
number
vaccin
strategi
develop
test
laboratori
anim
includ
recombin
vector
vaccin
express
sarscov
protein
dna
vaccin
inactiv
wholeviru
vaccin
recombinantprotein
vaccin
review
see
gillimross
subbarao
studi
show
protein
crucial
elicit
effect
protect
antibodi
respons
good
correl
neutralizingantibodi
titer
protect
challeng
anim
model
n
protein
induc
antigenspecif
tcellmedi
immun
respons
inactiv
wholeviru
vaccin
test
clinic
trial
china
human
monoclon
antibodi
neutral
sarscov
shown
protect
passiv
prophylaxi
immunotherapi
laboratori
anim
gillimross
subbarao
howev
absenc
reemerg
sar
littl
incent
pursu
initi
recent
year
seen
progress
toward
credibl
sar
vaccin
conclus
sar
outbreak
taught
us
mani
lesson
necess
develop
new
antivir
therapi
learn
lack
progress
detail
regard
antivir
past
year
equal
relev
develop
coronaviru
vaccin
essenti
reason
togeth
emerg
merscov
hope
articl
seri
help
chang
attitud
research
fund
polici
maker
time
around
